Adempa 10 mg (Tablet)
Unit Price: ৳ 25.00 (1 x 10: ৳ 250.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Unimed unihealth pharmaceuticals ltd |
| Also available as |
Title
- Adempa 10 mg Tablet
Categories
- Medicine
- Diabetes Care
- Cardiovascular Health
Description
- SGLT-2 inhibitor for improving glycemic control in adults with type 2 diabetes mellitus
- Reduces the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitor
Dosage & Administration
- Recommended dose: 10 mg once daily in the morning, with or without food
- Dose may be increased to 25 mg once daily in patients tolerating the medication
- Correction of volume depletion prior to initiation recommended
Pharmacology
- Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor
- Reduces renal absorption of glucose, leading to increased glucose excretion and reduced hyperglycemia
- Contributes to weight loss and reduces blood pressure
Indications
- Adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus
- Reduction of risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
Interaction
- Co-administration with diuretics results in increased urine volume
- Increased risk of hypoglycemia when co-administered with insulin or insulin secretagogues
- SGLT2 inhibitors lead to positive urine glucose tests and unreliable 1,5-AG assay in monitoring glycemic control
Contraindications
- History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients
- Severe renal impairment
- End-stage renal disease or dialysis
Side Effects
- Common: Urinary tract infections and female genital mycotic infections
- Other common side effects: Dehydration, hypotension, weakness, dizziness, increased thirst
Pregnancy & Lactation
- Limited data on use in pregnant women, potential benefits should justify potential risk to the fetus
- Not recommended during breastfeeding
Precautions & Warnings
- Assessment of renal function recommended prior to initiation
- Not initiated in patients with eGFR less than 45 ml/min/1.73 m²
- No dose adjustment needed in patients with eGFR ≥ 45 ml/min/1.73 m²
Overdose Effects
- Supportive measures recommended in case of overdose
- Hemodialysis efficacy not studied
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Store below 30°C, protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
Common Questions
- What is Adempa 10 mg Tablet?
- What is Adempa 10 mg Tablet used for?
- Are there any pregnancy warnings?
- Are there any breast-feeding warnings?
- Does this affect kidney function?
- Does this affect liver function?
- Quick Tips
Usability Features
- Used to control blood sugar and avoid long-term complications
- May cause loss of fluids and hypoglycemia, necessitating adequate hydration and regular blood sugar monitoring
- May cause genital fungal and urinary tract infections, requiring good hygiene practices
Technical Specifications
- Chemical Structure: C23H27ClO7
- Molecular Formula: C23H27ClO7
Design Elements
- Chemical structure image provided for reference
Materials
- Empagliflozin as the primary active ingredient